Genesist

Curated by Signal

Developer of CRISPR-based therapies to stop cancer metastasis and recurrence

Overview

Developer of CRISPR-based therapies to stop cancer metastasis and recurrence. It uses AI-powered evolutionary cell therapy to make stromal cells, the supportive cells surrounding a tumor, more resistant to cancer in order to prevent the cancer from spreading and metastasizing.

Key facts

Founded: 2022
Headquarters: Farmington, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Autism Diagnostic Technologies
Developer of software for autism diagnosis
Life Sciences TechnologyBasking Ridge, United States
Farsight Genome Systems
Diagnostic systems for pathology laboratories
Life Sciences TechnologySunnyvale, United States
Daytrana
Methylphenidate transdermal system for the management of ADHD
Life Sciences TechnologyMiami, United States

About Genesist

What does Genesist do?

Developer of CRISPR-based therapies to stop cancer metastasis and recurrence.

Where is Genesist headquartered?

Genesist is headquartered in Farmington, United States.

When was Genesist founded?

Genesist was founded in 2022.

Which sector is Genesist in?

Genesist operates in Life Sciences Technology.

Who are Genesist's competitors?

Companies similar to Genesist include Autism Diagnostic Technologies, Farsight Genome Systems, and Daytrana.